Findings of 18F‐PI‐2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample

• Main Authors: Shogyoku Bun (Author), Sho Moriguchi (Author), Toshiki Tezuka (Author), Yoshiaki Sato (Author), Keisuke Takahata (Author), Morinobu Seki (Author), Shinichiro Nakajima (Author), Yasuharu Yamamoto (Author), Yasunori Sano (Author), Natsumi Suzuki (Author), Ayaka Morimoto (Author), Ryo Ueda (Author), Hajime Tabuchi (Author), Daisuke Ito (Author), Masaru Mimura (Author)
• Format: Book
• Published: Wiley, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Alzheimer's disease (AD) is the most common cause of dementia worldwide. In AD, abnormal tau accumulates within neurons of the brain, facilitated by extracellular β‐amyloid deposition, leading to neurodegeneration, and eventually, cognitive impairment. As this process is tho...